stotes - agree that some slippage in timing is not all that important in the scheme of things. Getting it done right - even if it takes a year or two longer - is far more important. But being a researcher/planner, by profession, I will admit to being a bit obsessed about the accuracy/likelihood of scenarios and critical paths.
Regarding Scott's recent talks - the webinar and 'on the couch' - to me his most significant utterance was "exiting the R&D phase and moving into the commercialisation phase".
This perhaps infers that he now firmly believes that his software and hardware engineers and industrial designers have nailed the tech in terms of required sensitivity and specificity and, now, just have to demonstrate this (tick the box) via the validation trial. If so, this is huge.
- Forums
- ASX - By Stock
- EMV
- EMvision Research Notes
EMvision Research Notes, page-2616
-
- There are more pages in this discussion • 124 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EMV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.08 |
Change
-0.010(0.48%) |
Mkt cap ! $177.8M |
Open | High | Low | Value | Volume |
$2.09 | $2.14 | $2.06 | $68.41K | 32.60K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 379 | $2.08 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.10 | 250 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 379 | 2.080 |
2 | 5690 | 2.060 |
1 | 1500 | 2.050 |
4 | 8000 | 2.000 |
1 | 350 | 1.985 |
Price($) | Vol. | No. |
---|---|---|
2.100 | 250 | 1 |
2.110 | 10000 | 1 |
2.150 | 7000 | 1 |
2.200 | 14000 | 2 |
2.220 | 18000 | 1 |
Last trade - 13.07pm 21/10/2024 (20 minute delay) ? |
Featured News
EMV (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online